| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |